Cotinga Pharmaceuticals Closes $2.0M Private Placement
May 04, 2018 08:00 ET
|
Cotinga Pharmaceuticals Inc.
LONDON and BOSTON, May 04, 2018 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture:COT) (OTCQB:COTQF) (“Cotinga” or the “Company”), a clinical-stage pharmaceutical company advancing a...
Cotinga Pharmaceuticals Reports Fiscal 2018 Third Quarter Financial and Operating Results
April 03, 2018 17:00 ET
|
Cotinga Pharmaceuticals Inc.
LONDON, Ontario and BOSTON, April 03, 2018 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture:COT) (OTCQB:COTQF) (“Cotinga” or the “Company”), a clinical-stage pharmaceutical company...
Cotinga Pharmaceuticals Announces Presentation on COTI-2 at the American Association for Cancer Research (AACR) Annual Meeting 2018
April 03, 2018 08:00 ET
|
Cotinga Pharmaceuticals Inc.
LONDON, Ontario and BOSTON, April 03, 2018 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture:COT) (OTCQB:COTQF) (“Cotinga” or the “Company”), a clinical-stage pharmaceutical company...
Cotinga Pharmaceuticals Provides Update on COTI-2 Clinical Programs
March 20, 2018 07:00 ET
|
Cotinga Pharmaceuticals Inc.
LONDON, Ontario and BOSTON, March 20, 2018 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture:COT) (OTCQB:COTQF) (“Cotinga” or the “Company”), a clinical-stage pharmaceutical company...
Cotinga Pharmaceuticals to Present at 30th Annual ROTH Conference
March 06, 2018 07:00 ET
|
Cotinga Pharmaceuticals Inc.
LONDON, Ontario and BOSTON, Mass., March 06, 2018 (GLOBE NEWSWIRE) -- Cotinga Pharmaceuticals Inc. (TSX Venture:COT) (OTCQB:COTQF) (“Cotinga” or the “Company”), a clinical-stage pharmaceutical...